Filing metadata

Accession number
0000921895-21-000600
Form type
Form 3
Filer
Summit Therapeutics Inc.
CIK
CIK 1599298
Filed
Mar 02, 2021
Reporting period
Feb 26, 2021
Description
Initial ownership

Explore SEC Filings Hub